164 related articles for article (PubMed ID: 21129215)
1. Human immunome, bioinformatic analyses using HLA supermotifs and the parasite genome, binding assays, studies of human T cell responses, and immunization of HLA-A*1101 transgenic mice including novel adjuvants provide a foundation for HLA-A03 restricted CD8+T cell epitope based, adjuvanted vaccine protective against Toxoplasma gondii.
Cong H; Mui EJ; Witola WH; Sidney J; Alexander J; Sette A; Maewal A; McLeod R
Immunome Res; 2010 Dec; 6():12. PubMed ID: 21129215
[TBL] [Abstract][Full Text] [Related]
2. Toxoplasma gondii HLA-B*0702-restricted GRA7(20-28) peptide with adjuvants and a universal helper T cell epitope elicits CD8(+) T cells producing interferon-γ and reduces parasite burden in HLA-B*0702 mice.
Cong H; Mui EJ; Witola WH; Sidney J; Alexander J; Sette A; Maewal A; El Bissati K; Zhou Y; Suzuki Y; Lee D; Woods S; Sommerville C; Henriquez FL; Roberts CW; McLeod R
Hum Immunol; 2012 Jan; 73(1):1-10. PubMed ID: 22027386
[TBL] [Abstract][Full Text] [Related]
3. Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201.
Cong H; Mui EJ; Witola WH; Sidney J; Alexander J; Sette A; Maewal A; McLeod R
Vaccine; 2011 Jan; 29(4):754-62. PubMed ID: 21095258
[TBL] [Abstract][Full Text] [Related]
4. Protein nanovaccine confers robust immunity against
El Bissati K; Zhou Y; Paulillo SM; Raman SK; Karch CP; Roberts CW; Lanar DE; Reed S; Fox C; Carter D; Alexander J; Sette A; Sidney J; Lorenzi H; Begeman IJ; Burkhard P; McLeod R
NPJ Vaccines; 2017; 2():24. PubMed ID: 29263879
[TBL] [Abstract][Full Text] [Related]
5. Adjuvanted multi-epitope vaccines protect HLA-A*11:01 transgenic mice against
El Bissati K; Chentoufi AA; Krishack PA; Zhou Y; Woods S; Dubey JP; Vang L; Lykins J; Broderick KE; Mui E; Suzuki Y; Sa Q; Bi S; Cardona N; Verma SK; Fraczek L; Reardon CA; Sidney J; Alexander J; Sette A; Vedvick T; Fox C; Guderian JA; Reed S; Roberts CW; McLeod R
JCI Insight; 2016 Sep; 1(15):e85955. PubMed ID: 27699241
[TBL] [Abstract][Full Text] [Related]
6. Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans.
Tan TG; Mui E; Cong H; Witola WH; Montpetit A; Muench SP; Sidney J; Alexander J; Sette A; Grigg ME; Maewal A; McLeod R
Vaccine; 2010 May; 28(23):3977-89. PubMed ID: 20347630
[TBL] [Abstract][Full Text] [Related]
7. Engineering and characterization of a novel Self Assembling Protein for Toxoplasma peptide vaccine in HLA-A*11:01, HLA-A*02:01 and HLA-B*07:02 transgenic mice.
El Bissati K; Zhou Y; Paulillo SM; Raman SK; Karch CP; Reed S; Estes A; Estes A; Lykins J; Burkhard P; McLeod R
Sci Rep; 2020 Oct; 10(1):16984. PubMed ID: 33046728
[TBL] [Abstract][Full Text] [Related]
8. A Toxoplasma gondii vaccine encoding multistage antigens in conjunction with ubiquitin confers protective immunity to BALB/c mice against parasite infection.
Yin H; Zhao L; Wang T; Zhou H; He S; Cong H
Parasit Vectors; 2015 Sep; 8():498. PubMed ID: 26420606
[TBL] [Abstract][Full Text] [Related]
9. HLA Class I-T cell epitopes from trans-sialidase proteins reveal functionally distinct subsets of CD8+ T cells in chronic Chagas disease.
Alvarez MG; Postan M; Weatherly DB; Albareda MC; Sidney J; Sette A; Olivera C; Armenti AH; Tarleton RL; Laucella SA
PLoS Negl Trop Dis; 2008; 2(9):e288. PubMed ID: 18846233
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of a novel immunogenic nanoparticle platform for Toxoplasma peptide vaccine in HLA transgenic mice.
El Bissati K; Zhou Y; Dasgupta D; Cobb D; Dubey JP; Burkhard P; Lanar DE; McLeod R
Vaccine; 2014 May; 32(26):3243-8. PubMed ID: 24736000
[TBL] [Abstract][Full Text] [Related]
11. Protective CD8
Ma Y; Tang K; Zhang Y; Zhang C; Cheng L; Zhang F; Zhuang R; Jin B; Zhang Y
Virol J; 2020 Oct; 17(1):146. PubMed ID: 33028368
[TBL] [Abstract][Full Text] [Related]
12. Human MHC class I molecule, HLA-A2.1, mediates activation of CD8
Mani R; Abdelaziz MH; Michelon A; Suzuki Y
Front Immunol; 2022; 13():1005059. PubMed ID: 36311799
[TBL] [Abstract][Full Text] [Related]
13. HLA-A02:01-restricted epitopes identified from the herpes simplex virus tegument protein VP11/12 preferentially recall polyfunctional effector memory CD8+ T cells from seropositive asymptomatic individuals and protect humanized HLA-A*02:01 transgenic mice against ocular herpes.
Srivastava R; Khan AA; Spencer D; Vahed H; Lopes PP; Thai NT; Wang C; Pham TT; Huang J; Scarfone VM; Nesburn AB; Wechsler SL; BenMohamed L
J Immunol; 2015 Mar; 194(5):2232-48. PubMed ID: 25617474
[TBL] [Abstract][Full Text] [Related]
14. Promiscuous Recognition of a Trypanosoma cruzi CD8+ T Cell Epitope among HLA-A2, HLA-A24 and HLA-A1 Supertypes in Chagasic Patients.
Lasso P; Beltrán L; Guzmán F; Rosas F; Thomas MC; López MC; González JM; Cuéllar A; Puerta CJ
PLoS One; 2016; 11(3):e0150996. PubMed ID: 26974162
[TBL] [Abstract][Full Text] [Related]
15. Development and preclinical safety evaluation of a new therapeutic HIV-1 vaccine based on 18 T-cell minimal epitope peptides applying a novel cationic adjuvant CAF01.
Fomsgaard A; Karlsson I; Gram G; Schou C; Tang S; Bang P; Kromann I; Andersen P; Andreasen LV
Vaccine; 2011 Sep; 29(40):7067-74. PubMed ID: 21767590
[TBL] [Abstract][Full Text] [Related]
16. A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models.
Lambert SL; Aslam S; Stillman E; MacPhail M; Nelson C; Ro B; Sweetwood R; Lei YM; Woo JC; Tang RS
PLoS One; 2015; 10(3):e0119509. PubMed ID: 25793508
[TBL] [Abstract][Full Text] [Related]
17. Design of multi-epitope peptides containing HLA class-I and class-II-restricted epitopes derived from immunogenic Leishmania proteins, and evaluation of CD4+ and CD8+ T cell responses induced in cured cutaneous leishmaniasis subjects.
Hamrouni S; Bras-Gonçalves R; Kidar A; Aoun K; Chamakh-Ayari R; Petitdidier E; Messaoudi Y; Pagniez J; Lemesre JL; Meddeb-Garnaoui A
PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008093. PubMed ID: 32176691
[TBL] [Abstract][Full Text] [Related]
18. Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpesvirus Infection.
Srivastava R; Khan AA; Garg S; Syed SA; Furness JN; Vahed H; Pham T; Yu HT; Nesburn AB; BenMohamed L
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847359
[TBL] [Abstract][Full Text] [Related]
19. Immunity in the spleen and blood of mice immunized with irradiated Toxoplasma gondii tachyzoites.
Zorgi NE; Galisteo AJ; Sato MN; do Nascimento N; de Andrade HF
Med Microbiol Immunol; 2016 Aug; 205(4):297-314. PubMed ID: 26732075
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of in-silico designed multi-epitope DNA vaccine encoding SAG1, SAG3 and SAG5 of Toxoplasma gondii adjuvanted with CpG-ODN against acute toxoplasmosis in BALB/c mice.
Khodadadi M; Ghaffarifar F; Dalimi A; Ahmadpour E
Acta Trop; 2021 Apr; 216():105836. PubMed ID: 33485872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
